Introduction
In 2006, zoster vaccine live was recommended for adults aged ≥60 years. In 2011, zoster
vaccine live was approved for use but not recommended for adults aged 50–59 years.
This study assessed zoster vaccine live coverage among adults aged 50–59 years and
≥60 years.
Methods
Data from the 2013–2017 National Health Interview Surveys were analyzed in 2019 to estimate national
zoster vaccine live coverage among adults aged ≥50 years. State-specific zoster vaccine
live coverage among adults aged ≥50 years was assessed using 2017 Behavioral Risk
Factor Surveillance System data.
Results
Among adults aged 50–59 years, zoster vaccine live coverage was 5.7% in 2017, ranging
from 4% to 6% during 2013–2017 (test for trend, p>0.05). Zoster vaccine live coverage among adults aged 50–59 years ranged from 5.8%
in Pennsylvania to 14.7% in South Dakota. By 2017, zoster vaccine live was received
by 34.9% of adults aged ≥60 years, a significant increase from 24.2% in 2013. Zoster
vaccine live coverage among adults aged ≥60 years in 2017 ranged from 26.0% in Mississippi
to 51.8% in Vermont. In 2017, major characteristics significantly associated with
increased likelihood of zoster vaccine live vaccination among adults aged 50–59 years
and ≥60 years were older age, having 4 to 9 physician contacts in the past 12 months,
and having a usual place for health care.
Conclusions
This study provides an assessment of zoster vaccine live coverage among adults aged
≥50 years before the newly recommended recombinant zoster vaccine came into widespread
use. Providers should routinely assess adults’ vaccination status and strongly recommend
or offer needed vaccines to their patients.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of Preventive MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
REFERENCES
- What does epidemiology tell us about risk factors for herpes zoster?.Lancet Infect Dis. 2004; 4: 26-33
- A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.N Engl J Med. 2005; 352: 2271-2284
- A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction.Mayo Clin Proc. 2007; 82: 1341-1349
- Seward JF; Advisory Committee on Imunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2008; 57: 1-CE4
- Update on herpes zoster vaccine: licensure for persons aged 50 through 59 years.MMWR Morb Mortal Wkly Rep. 2011; 60: 1528
- Centers for Disease Control and Prevention (CDC). Update on recommendations for use of herpes zoster vaccine.MMWR Morb Mortal Wkly Rep. 2014; 63: 729-731
- Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines.MMWR Morb Mortal Wkly Rep. 2018; 67: 103-108
- National Health Interview Survey; 2017.2018ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHIS/2017/srvydesc.pdf(Published July 17,)Date accessed: November 15, 2019
- Behavioral Risk Factor Surveillance System: overview– BRFSS 2017.2018www.cdc.gov/brfss/annual_data/2017/pdf/overview-2017-508.pdf(Published July 16,)Date accessed: June 8, 2019
- The Behavioral Risk Factor Surveillance System: 2017 summary data quality report.2018www.cdc.gov/brfss/annual_data/2017/pdf/2017-sdqr-508.pdf(Published July 13,)Date accessed: June 8, 2019
HHS. Immunization and infectious diseases.www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives. Accessed January 15, 2019.
- Barriers to the use of herpes zoster vaccine.Ann Intern Med. 2010; 152: 555-560
- Vaccines provided by family physicians.Ann Fam Med. 2010; 8: 507-510
- Effect of pharmacist intervention on herpes zoster vaccination in community pharmacies.J Am Pharm Assoc. 2013; 53: 46-53
- The role of attitudes in understanding disparities in adult influenza vaccination.Am J Prev Med. 2006; 31: 281-285
- Racial and ethnic disparities in influenza vaccination coverage among adults during the 2004-2005 season.Am J Epidemiol. 2006; 163: 571-578
- Primary care physicians who treat blacks and whites.N Engl J Med. 2004; 351: 575-584
- Racial disparities in the quality of care for enrollees in Medicare managed care.JAMA. 2002; 287: 1288-1294
- Differences in physician prevention practice patterns for white and minority patients.J Community Health. 1988; 13: 53-64
- Seasonal influenza vaccination of adult populations, United States, 2005-2011.Am J Epidemiol. 2013; 178: 1478-1487
- Surveillance of influenza vaccination coverage – United States, 2007-08 through 2011-12 influenza seasons.MMWR Surveill Summ. 2013; 62: 1-28
- Racial and ethnic disparities in vaccination coverage among adult populations in the U.S.Am J Prev Med. 2015; 49: S412-S425
- Report to congressional committees. Medicare—many factors, including administrative challenges, affect access to Part D vaccinations.2011www.gao.gov/products/GAO-12-61(Published December)Date accessed: October 10, 2019
- State health department structure and pandemic planning.J Public Health Manag Pract. 2010; 16: E1-E7
- State trends in health risk factors and receipt of clinical preventive services among U.S. adults during the 1990s.JAMA. 2002; 287: 2659-2667
- State- and sex-specific prevalence of selected characteristics – Behavioral Risk Factor Surveillance System, 1996 and 1997.MMWR CDC Surveill Summ. 2000; 49: 1-39
- Surveillance for certain health behaviors among selected local areas – Behavioral Risk Factor Surveillance System, 2011.MMWR Surveill Summ. 2014; 63: 1-149
- Influenza vaccination coverage among people with high-risk conditions in the U.S.Am J Prev Med. 2016; 50: e15-e26
- AdultVaxView.2019www.cdc.gov/vaccines/imz-managers/coverage/adultvaxview/data-reports/general-population/reports/2017.html(Updated May 2,)Date accessed: June 25, 2019
- FluVaxView.2019www.cdc.gov/flu/fluvaxview/(Updated September 26,)Date accessed: February 22, 2019
- Guide to community preventive services.2018www.thecommunityguide.org/index.html(Updated February 15,)Date accessed: June 19, 2019
- Impact of health insurance status on vaccination coverage among adult populations.Am J Prev Med. 2015; 48: 647-661
- Hepatitis B vaccination coverage among adults–United States, 2004.MMWR Morb Mortal Wkly Rep. 2006; 55: 509-511
- NHIS questionnaire - sample adult; 2018.2019ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Survey_Questionnaires/NHIS/2018/english/qadult.pdf(Published June 12,)Date accessed: October 6, 2019
- Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors.Vaccine. 2013; 31: 3928-3935
- Recommendations from the National Vaccine Advisory Committee: standards for adult immunization practice.Public Health Rep. 2014; 129: 115-123
- Shingles (herpes zoster): vaccination.2019www.cdc.gov/shingles/vaccination.html(Updated July 1,)Date accessed: October 19, 2019
Article info
Publication history
Published online: May 07, 2020
Identification
Copyright
Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine.
